WHWK Whitehawk Therapeutics, Inc. - Common Stock
$4,69
Prezzo · Ago 18, 2026
Fondamentali al Ago 6, 2026
Intervallo 52 sett.
$2–$5
79% of range
Rating Analisti
BUY
14 analysts
Prezzo Obiettivo
$8
+60% upside
P/E (TTM)
-14.2
ROE
-13.4%
Margine di Profitto Netto
-288.3%
WHWK Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.69
Capitalizzazione di Mercato
$221M
P/E (TTM)
-14.2
EPS (TTM)
$-0.33
Ricavi (TTM)
$7M
Rendimento div.
—
ROE
-13.4%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$2 – $5
WHWK Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$7M
2018-12-31
→
2025-12-31
EPS
$-0.33
2021-12-31
→
2025-12-31
Flusso di cassa libero
$-98M
2018-12-31
→
2025-12-31
Margini
-288.3%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
WHWK
Mediana dei peer
P/E (TTM)
-14.2
1.2
P/S (TTM)
31.0
6.3
P/B
1.6
1.6
Price / FCF (Prezzo / FCF)
-2.3
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
WHWK
Mediana dei peer
Operating Margin (Margine Operativo)
-1601.1%
—
Net Profit Margin (Margine di Profitto Netto)
-288.3%
-312.6%
ROA
-18.6%
-56.8%
ROE
-13.4%
-83.3%
ROIC
-83.9%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
WHWK
Mediana dei peer
Current Ratio (Rapporto corrente)
10.3
8.5
Quick Ratio
10.0
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
WHWK
Mediana dei peer
Revenue YoY (Ricavi YoY)
-72.5%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
-22.3%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
-12.6%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
WHWK
Mediana dei peer
WHWK Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
14 analisti
- Acquisto forte 4 28,6%
- Compra 6 42,9%
- Mantieni 4 28,6%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
6 analisti · 2026-08-15
Mediana
$7.50
Ora
$4.69
Basso
$4.00
Alto
$10.00
Target mediano
$7.50
+59,9%
Target medio
$7.50
+59,9%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.25%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.20 | $-0.30 | 0.10% |
| 31 Marzo 2026 | $-0.32 | $-0.36 | 0.04% |
| 31 Dicembre 2025 | $-0.34 | $-0.16 | -0.18% |
| 30 Settembre 2025 | $-0.26 | $0.07 | -0.33% |
| 30 Giugno 2025 | $-0.76 | $0.50 | -1.3% |
| 31 Marzo 2025 | $-0.37 | $-0.47 | 0.10% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Cost of Revenue | $760.0K | $3M | $3M | $1M | $0 | · | · | · | |
| R&D Expense | $91M | $51M | $49M | $33M | $20M | $15M | $13M | $18M | |
| SG&A Expense | $30M | $37M | $45M | $40M | $19M | $2M | $10M | $13M | |
| Operating Expenses | $122M | $93M | $96M | $78M | $112M | $17M | $24M | $31M | |
| Operating Income | $-114M | $-67M | $-72M | $-63M | $-111M | $-3M | $-24M | $-11M | |
| Interest Expense | · | · | $231.0K | $230.0K | $665.0K | $815.0K | · | · | |
| Interest Income | $6M | $4M | $6M | $2M | $13.0K | $41.0K | · | · | |
| Other Non-op | $94M | $4M | $6M | $2M | $1M | $-927.0K | $1M | $784.6K | |
| Pretax Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $2.0K | $2.0K | · | · | |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| EPS (Basic) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| Shares (Basic) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| Shares (Diluted) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| EBITDA | $-114M | $-67M | $-72M | $-63M | $-111M | $-6M | $-24M | $-11M |
Stato Patrimoniale 25
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $29M | $63M | $39M | $149M | $4M | $39M | $63M | |
| Short-term Investments | $108M | $19M | $46M | $134M | $0 | · | · | · | |
| Receivables | $0 | $6M | $5M | $2M | $0 | $14M | · | · | |
| Inventory | $0 | $5M | $6M | $2M | $0 | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $2M | $81.0K | $311.2K | $754.4K | |
| Other Current Assets | · | · | · | · | · | $2M | $734.8K | $615.7K | |
| Current Assets | $149M | $61M | $125M | $180M | $151M | $19M | $40M | $64M | |
| PP&E (Net) | $3.0K | $7M | $5M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K | |
| PP&E (Gross) | $377.0K | $7M | $5M | $609.0K | $87.0K | $512.1K | $493.0K | $409.6K | |
| Accum. Depreciation | $374.0K | $463.0K | $270.0K | $101.0K | $30.0K | $390.3K | $328.9K | $311.1K | |
| Intangibles | · | · | · | $0 | $4M | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2M | $2M | $2M | · | · | · | |
| Total Assets | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Accounts Payable | $917.0K | $2M | $6M | $4M | $6M | $2M | $439.8K | $595.7K | |
| Accrued Liabilities | $14M | $15M | $14M | $15M | $9M | $4M | · | · | |
| Current Liabilities | $15M | $17M | $26M | $19M | $15M | $30M | $3M | $5M | |
| Capital Leases | $0 | $565.0K | $833.0K | $1M | $474.0K | · | $67.4K | · | |
| Other Non-current Liabilities | $0 | $202.0K | $0 | · | $0 | $97.0K | · | · | |
| Total Liabilities | $15M | $18M | $27M | $26M | $22M | $31M | $3M | $5M | |
| Common Stock | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $4.1K | $4.1K | |
| Retained Earnings | $-353M | $-333M | $-269M | $-203M | $-143M | $-33M | $-142M | $-119M | |
| AOCI | $120.0K | $16.0K | $27.0K | $-115.0K | $0 | · | · | · | |
| Stockholders' Equity | $136M | $52M | $105M | $158M | $136M | $-12M | $-9M | $59M | |
| Liabilities + Equity | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Shares Outstanding | 47,145,719 | 24,681,000 | 24,554,000 | 24,435,000 | 20,895,000 | 2,542,358 | 40,588,004 | 40,588,004 |
Flusso di cassa 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $193.0K | $169.0K | $159.0K | $105.0K | $9.0K | · | · | |
| Stock-based Comp | $10M | $11M | $12M | $10M | $2M | $139.0K | $1M | $3M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $87.0K | $95.0K | $0 | · | · | |
| Restructuring | $0 | $3M | $0 | · | · | · | · | · | |
| Other Non-cash | $-87M | $-7M | $-6M | $1M | $85M | · | · | · | |
| Operating Cash Flow | $-97M | $-60M | $-60M | $-50M | $-22M | $-13M | $-24M | $-6M | |
| CapEx | $552.0K | $2M | $4M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | |
| Investing Cash Flow | $12M | $25M | $83M | $-133M | $25M | $-19.0K | $-237.0K | $-37.9K | |
| Stock Issued | · | · | · | $0 | $155M | $10M | · | $52M | |
| Net Stock Activity | · | · | · | $0 | $155M | $10M | · | $52M | |
| Dividends Paid | · | · | · | $0 | $4M | · | · | · | |
| Financing Cash Flow | $94M | $130.0K | $326.0K | $73M | $142M | $1M | · | $48M | |
| Net Change in Cash | $9M | $-34M | $24M | $-110M | $145M | $-12M | $-24M | $42M | |
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M | $-5M | $-24M | $-6M | |
| Levered FCF | · | · | $-64M | $-50M | $-23M | · | · | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -42.4% | · | -55.5% | |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -28.8% | · | -51.6% | |
| Pretax Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.3% | · | · | · | |
| EBITDA Margin | -1600.0% | -258.9% | -294.7% | -410.9% | -9920.7% | -42.4% | · | -55.5% | |
| ROA | -18.6% | -62.8% | -41.5% | -35.4% | -124.6% | -10.2% | -44.7% | -24.4% | |
| ROE | -13.4% | -105.0% | -58.9% | -37.0% | -76.6% | -38.2% | -59.5% | -16.6% | |
| ROIC | -83.9% | -128.6% | -68.4% | -39.6% | -81.5% | · | · | · |
Liquidità e Solvibilità 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 | 24.0 | 11.9 | 11.7 | |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 | 22.8 | 11.6 | 11.5 | |
| Interest Coverage | · | · | -311.4 | -272.5 | -167.2 | · | · | · |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.3 | 0.2 | 0.1 | 0.0 | 0.4 | · | 0.5 | |
| Inventory Turnover | 0.3 | 0.5 | 0.7 | 1.4 | · | · | · | · | |
| Receivables Turnover | 2.4 | 4.6 | 6.6 | 16.3 | · | · | · | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -72.5% | 6.7% | 60.1% | 8.7% | 0.00% | · | · | · | |
| Revenue CAGR 3Y | -22.3% | 22.9% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -12.6% | · | · | · | · | · | · | · |
Valutazione (TTM) 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Net Income TTM | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| Market Cap | $114M | $78M | $50M | $314M | $505M | $695M | $380M | $1.03B | |
| P/E | -7.3 | -1.3 | -0.8 | -4.8 | -1.9 | · | · | · | |
| P/S | 16.0 | 3.0 | 2.0 | 20.6 | 36.0 | 49.6 | · | 51.3 | |
| P/B | 0.8 | 1.5 | 0.5 | 2.0 | 3.7 | 16.1 | 10.4 | 17.6 | |
| P / Tangible Book | 0.8 | 1.5 | 0.5 | 2.0 | 3.8 | · | · | · | |
| P / Cash Flow | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -129.0 | -15.9 | -178.2 | |
| P / FCF | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -128.5 | -15.8 | -177.0 | |
| Dividend Yield | · | · | · | 0.00% | 0.87% | · | · | · | |
| Earnings Yield | -13.6% | -74.8% | -120.8% | -21.0% | -51.4% | · | · | · | |
| Payout Ratio | · | · | · | 0.00% | -4.0% | · | · | · | |
| Annual Payout | · | · | · | $0 | $4M | · | · | · |
Conto Economico 17
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $760.0K | $790.0K | $804.0K | $778.0K | $652.0K | $927.0K | $697.0K | $656.0K | $529.0K | $222.0K | $593.0K | |
| R&D Expense | $13M | $17M | $19M | $14M | $49M | $9M | $14M | $10M | $13M | $14M | $13M | $12M | $13M | $11M | $9M | $9M | |
| SG&A Expense | $5M | $6M | $6M | $5M | $6M | $13M | $11M | $7M | $8M | $11M | $10M | $11M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $18M | $24M | $25M | $20M | $55M | $22M | $26M | $21M | $22M | $25M | $24M | $24M | $26M | $23M | $21M | $19M | |
| Operating Income | $-18M | $-24M | $-25M | $-20M | $-55M | $-15M | $-19M | $-13M | $-16M | $-20M | $-18M | $-18M | $-20M | $-17M | $-15M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $58.0K | · | $58.0K | $58.0K | $58.0K | $56.0K | $58.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $791.0K | $676.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $620.0K | |
| Other Non-op | $1M | $1M | $2M | $2M | $2M | $88M | $676.0K | $867.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $562.0K | |
| Pretax Income | $-17M | $-22M | · | · | $-53M | $73M | · | · | · | · | $-16M | $-16M | $-18M | · | $-14M | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Net Income | $-17M | $-22M | $-23M | $-18M | $-53M | $73M | $-18M | $-13M | $-15M | $-18M | $-16M | $-16M | $-18M | $-15M | $-14M | $-14M | |
| EPS (Basic) | $-0.20 | $-0.32 | $-1.15 | $-0.26 | $-0.76 | $1.84 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| EPS (Diluted) | $-0.20 | $-0.32 | $-1.14 | $-0.26 | $-0.76 | $1.83 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| Shares (Basic) | 82,886,196 | 69,236,945 | -116,042,087 | 69,204,899 | 69,083,127 | 39,640,826 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| Shares (Diluted) | 82,886,196 | 69,236,945 | -116,333,800 | 69,204,899 | 69,083,127 | 39,932,539 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| EBITDA | $-18M | $-24M | · | $-20M | $-55M | $-15M | · | $-13M | $-16M | $-19M | · | $-18M | $-20M | $-17M | · | $-15M |
Stato Patrimoniale 24
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $35M | $38M | $38M | $145M | $228M | $29M | $31M | $41M | $54M | $63M | $69M | $68M | $34M | $39M | $135M | |
| Short-term Investments | $105M | $88M | $108M | $125M | $32M | $3M | $19M | $32M | $37M | $34M | $46M | $51M | $67M | $117M | $134M | $48M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $6M | $5M | $5M | $6M | $4M | $6M | $2M | $2M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $2M | $734.0K | |
| Prepaid Expense | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Current Assets | $192M | $126M | $149M | $165M | $179M | $233M | $61M | $77M | $93M | $103M | $125M | $133M | $145M | $165M | $180M | $190M | |
| PP&E (Net) | $1.0K | $2.0K | $3.0K | $4.0K | $9.0K | $25.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $508.0K | $457.0K | |
| PP&E (Gross) | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $609.0K | · | |
| Accum. Depreciation | $376.0K | $375.0K | $374.0K | $373.0K | $368.0K | $352.0K | $463.0K | $416.0K | $369.0K | $320.0K | $270.0K | $226.0K | $183.0K | $140.0K | $101.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Accounts Payable | $1M | $2M | $917.0K | $2M | $3M | $4M | $2M | $1M | $2M | $3M | $6M | $3M | $3M | $7M | $4M | $4M | |
| Accrued Liabilities | $10M | $9M | $14M | $8M | $5M | $9M | $15M | $14M | $14M | $11M | $14M | $12M | $10M | $11M | $15M | $14M | |
| Current Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $17M | $16M | $22M | $20M | $26M | $21M | $13M | $18M | $19M | $18M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $565.0K | $624.0K | $682.0K | $738.0K | $833.0K | $946.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $202.0K | $393.0K | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $18M | $17M | $23M | $21M | $27M | $21M | $20M | $25M | $26M | $25M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-392M | $-375M | $-353M | $-330M | $-312M | $-260M | $-333M | $-314M | $-302M | $-287M | $-269M | $-253M | $-236M | $-218M | $-203M | $-189M | |
| AOCI | $-63.0K | $-15.0K | $120.0K | $139.0K | $9.0K | $1.0K | $16.0K | $39.0K | $-27.0K | $-8.0K | $27.0K | $-16.0K | $-44.0K | $-32.0K | $-115.0K | $-99.0K | |
| Stockholders' Equity | $183M | $116M | $136M | $157M | $172M | $222M | $52M | $69M | $79M | $90M | $105M | $118M | $131M | $146M | $158M | $169M | |
| Liabilities + Equity | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Shares Outstanding | 57,009,010 | 47,196,564 | 47,145,719 | 47,128,362 | 47,128,362 | 46,784,618 | 24,680,708 | 24,614,834 | 24,614,834 | 24,554,205 | 24,554,205 | 24,525,860 | 24,519,860 | 24,436,990 | 24,435,007 | 24,395,117 |
Flusso di cassa 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $50.0K | $44.0K | $44.0K | $43.0K | $38.0K | $46.0K | $12.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-32.0K | $0 | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $-17M | $-15M | $-53M | $-12M | $-15M | $-16M | $-9M | $-20M | $-10M | $-12M | $-17M | $-21M | $-11M | $-8M | |
| CapEx | $0 | $0 | $0 | $0 | $1.0K | $551.0K | $186.0K | $188.0K | $541.0K | $739.0K | $816.0K | $1M | $689.0K | $1M | $78.0K | $102.0K | |
| Investing Cash Flow | $-17M | $19M | $17M | $-92M | $-29M | $115M | $13M | $5M | $-4M | $11M | $4M | $13M | $51M | $16M | $-84M | $-48M | |
| Financing Cash Flow | $82M | $0 | $25.0K | $0 | $-850.0K | $95M | $53.0K | $0 | $87.0K | $-10.0K | $80.0K | $-75.0K | $313.0K | $8.0K | $-107.0K | $73M | |
| Net Change in Cash | $50M | $-3M | $-363.0K | $-107M | $-83M | $199M | $-2M | $-11M | $-13M | $-9M | $-6M | $641.0K | $34M | $-5M | $-96M | $16M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Free Cash Flow | · | $-22M | · | · | · | $-12M | · | · | · | $-20M | · | · | · | $-23M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -364.5% | · | -299.5% | -315.1% | -286.8% | · | -354.2% | |
| Net Margin | · | · | · | · | · | 1021.9% | · | -174.0% | -236.0% | -341.7% | · | -273.6% | -289.8% | -259.5% | · | -341.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -273.6% | -289.8% | · | · | -341.0% | |
| EBITDA Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -363.6% | · | -299.5% | -315.1% | -286.1% | · | -354.2% | |
| ROA | -8.9% | -12.3% | · | -14.0% | -37.3% | 42.3% | · | -11.1% | -11.5% | -13.0% | · | -9.8% | -12.8% | -9.7% | · | -8.0% | |
| ROE | -9.4% | -13.1% | · | -15.7% | -41.9% | 46.8% | · | -13.4% | -13.9% | -15.5% | · | -11.3% | -15.0% | -11.2% | · | -9.0% | |
| ROIC | -9.9% | -20.2% | · | · | · | · | · | · | · | · | · | -15.1% | -14.9% | · | · | -8.9% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.4 | 11.4 | · | 16.8 | 20.4 | 19.0 | · | 4.9 | 4.2 | 5.2 | · | 6.5 | 11.2 | 9.3 | · | 10.6 | |
| Quick Ratio | 17.2 | 11.1 | · | 16.5 | 20.2 | 18.8 | · | 4.4 | 3.8 | 4.7 | · | 6.1 | 10.7 | 8.8 | · | 10.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -336.4 | · | -307.7 | -337.0 | -290.1 | · | -259.2 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.3 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | 1.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 2.9 | · | 1.2 | 1.3 | 1.0 | · | 1.5 | 2.2 | 1.4 | · | 3.7 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $7M | · | $14M | $21M | $26M | · | $25M | $24M | $23M | · | $22M | $20M | $16M | · | $10M | |
| Net Income TTM | $-109M | $-20M | · | $-10M | $-7M | $28M | · | $-62M | $-67M | $-68M | · | $-64M | $-66M | $-62M | · | $-134M | |
| Market Cap | $261M | $163M | · | $90M | $88M | $83M | · | $51M | $36M | $57M | · | $119M | $168M | $177M | · | $345M | |
| P/E | -3.0 | 7.0 | · | 5.4 | 26.7 | 11.9 | · | -0.9 | -0.6 | -0.9 | · | -1.9 | -2.5 | -2.6 | · | -1.2 | |
| P/S | · | 22.8 | · | 6.2 | 4.3 | 3.2 | · | 2.1 | 1.5 | 2.5 | · | 5.3 | 8.5 | 11.2 | · | 34.5 | |
| P/B | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Tangible Book | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -7.3 | · | · | · | -7.0 | · | · | · | -2.9 | · | · | · | -8.3 | · | · | |
| P / FCF | · | -7.3 | · | · | · | -6.7 | · | · | · | -2.8 | · | · | · | -7.8 | · | · | |
| Earnings Yield | -33.6% | 14.2% | · | 18.4% | 3.7% | 8.4% | · | -110.7% | -170.6% | -107.7% | · | -52.1% | -40.8% | -38.4% | · | -80.5% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $7M | $26M | $24M | $15M | $14M |
| Margine Operativo % | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% |
| Utile netto | $-21M | $-64M | $-66M | $-61M | $-110M |
| EPS Diluito | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-98M | $-61M | $-64M | $-50M | $-22M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 84 filer · $187.5M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 32 (+13 vs trimestre precedente) | 11 (+7 vs trimestre precedente) | 25 (+11 vs trimestre precedente) | 12 (+4 vs trimestre precedente) | +8.5M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Yu Fan | $22.264.818 | 4.861.314 | 11,87% | Azioni |
| ACUTA CAPITAL PARTNERS, LLC | $21.461.477 | 4.685.912 | 11,44% | Azioni |
| QVT Financial LP | $21.139.947 | 4.615.709 | 11,27% | Azioni |
| MONTANOVA CAPITAL, LLC | $19.694.000 | 4.300.000 | 10,50% | Azioni |
| ORBIMED ADVISORS LLC | $18.019.076 | 3.934.296 | 9,61% | Azioni |
| Avoro Capital Advisors LLC | $13.050.261 | 2.849.402 | 6,96% | Azioni |
| Siren, L.L.C. | $10.703.927 | 2.337.102 | 5,71% | Azioni |
| KVP Capital Advisors, LP | $9.920.266 | 2.165.997 | 5,29% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.359.609 | 1.388.561 | 3,39% | Azioni |
| ADAR1 Capital Management, LLC | $6.143.585 | 1.341.394 | 3,28% | Azioni |
| ACORN CAPITAL ADVISORS, LLC | $5.218.283 | 1.139.363 | 2,78% | Azioni |
| STEMPOINT CAPITAL LP | $4.676.349 | 1.021.037 | 2,49% | Azioni |
| Ally Bridge Group (NY) LLC | $3.746.161 | 817.939 | 2,00% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $3.495.462 | 762.997 | 1,86% | Azioni |
| Woodline Partners LP | $1.999.692 | 436.614 | 1,07% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.895.305 | 413.822 | 1,01% | Azioni |
| STATE STREET CORP | $1.772.378 | 386.982 | 0,95% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $1.742.259 | 380.406 | 0,93% | Azioni |
| Eversept Partners, LP | $1.389.141 | 303.306 | 0,74% | Azioni |
| Verdad Advisers, LP | $1.380.792 | 301.483 | 0,74% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $1.358.483 | 296.612 | 0,72% | Azioni |
| AMES NATIONAL CORP | $1.333.269 | 4.571 | 0,71% | Azioni |
| Balyasny Asset Management L.P. | $1.319.576 | 288.117 | 0,70% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.130.834 | 246.907 | 0,60% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.004.014 | 219.217 | 0,54% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $757.001 | 165.284 | 0,40% | Azioni |
| VANGUARD GROUP INC | $519.881 | 214.827 | 0,28% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $361.051 | 78.832 | 0,19% | Azioni |
| GOLDMAN SACHS GROUP INC | $349.060 | 76.214 | 0,19% | Azioni |
| Point72 Asset Management, L.P. | $261.651 | 57.129 | 0,14% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $237.427 | 51.840 | 0,13% | Azioni |
| Qube Research & Technologies Ltd | $224.388 | 48.993 | 0,12% | Azioni |
| UBS Group AG | $210.098 | 45.873 | 0,11% | Azioni |
| Nuveen, LLC | $200.599 | 43.799 | 0,11% | Azioni |
| Jump Financial, LLC | $186.864 | 40.800 | 0,10% | Azioni |
| DEUTSCHE BANK AG\ | $145.039 | 31.668 | 0,08% | Azioni |
| Bank of New York Mellon Corp | $132.623 | 28.957 | 0,07% | Azioni |
| WELLS FARGO & COMPANY/MN | $124.457 | 27.174 | 0,07% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $123.761 | 27.022 | 0,07% | Azioni |
| RHUMBLINE ADVISERS | $112.338 | 24.529 | 0,06% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $111.583 | 24.363 | 0,06% | Azioni |
| TWO SIGMA ADVISERS, LP | $102.608 | 42.400 | 0,05% | Azioni |
| Vanguard Global Advisers, LLC | $89.205 | 19.477 | 0,05% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $85.646 | 18.700 | 0,05% | Azioni |
| BANK OF AMERICA CORP /DE/ | $85.518 | 18.672 | 0,05% | Azioni |
| XTX Topco Ltd | $84.831 | 18.522 | 0,05% | Azioni |
| CITADEL ADVISORS LLC | $79.440 | 17.345 | 0,04% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $68.434 | 14.942 | 0,04% | Azioni |
| ABG Innovation Capital Partners III GP Ltd | $64.532 | 26.666 | 0,03% | Azioni |
| CITIGROUP INC | $60.209 | 13.146 | 0,03% | Azioni |
| JPMORGAN CHASE & CO | $59.323 | 13.452 | 0,03% | Azioni |
| Invesco Ltd. | $59.261 | 12.939 | 0,03% | Azioni |
| EVERGREEN CAPITAL MANAGEMENT LLC | $50.380 | 11.000 | 0,03% | Azioni |
| Scientech Research LLC | $49.638 | 10.838 | 0,03% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $46.739 | 10.205 | 0,02% | Azioni |
| Quadrature Capital Ltd | $46.002 | 10.044 | 0,02% | Azioni |
| TWO SIGMA SECURITIES, LLC | $45.951 | 10.033 | 0,02% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $31.804 | 6.944 | 0,02% | Azioni |
| NORTHERN TRUST CORP | $23.239 | 5.074 | 0,01% | Azioni |
| BARCLAYS PLC | $22.182 | 4.843 | 0,01% | Azioni |
| US BANCORP \DE\ | $15.265 | 3.333 | 0,01% | Azioni |
| Legal & General Group Plc | $14.482 | 3.162 | 0,01% | Azioni |
| Ameritas Investment Partners, Inc. | $13.488 | 2.945 | 0,01% | Azioni |
| Russell Investments Group, Ltd. | $11.880 | 2.594 | 0,01% | Azioni |
| Tower Research Capital LLC (TRC) | $11.702 | 2.555 | 0,01% | Azioni |
| BlackRock, Inc. | $11.601 | 2.533 | 0,01% | Azioni |
| OSAIC HOLDINGS, INC. | $7.048 | 1.539 | 0,00% | Azioni |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | $6.105 | 1.333 | 0,00% | Azioni |
| ROYAL BANK OF CANADA | $5.000 | 1.114 | 0,00% | Azioni |
| MORGAN STANLEY | $3.490 | 762 | 0,00% | Azioni |
| Sterling Capital Management LLC | $2.995 | 654 | 0,00% | Azioni |
| SATTER MANAGEMENT CO., L.P. | $2.079 | 659 | 0,00% | Azioni |
| SBI Securities Co., Ltd. | $1.452 | 317 | 0,00% | Azioni |
| Quarry LP | $998 | 218 | 0,00% | Azioni |
| TD Waterhouse Canada Inc. | $993 | 232 | 0,00% | Azioni |
| FMR LLC | $779 | 170 | 0,00% | Azioni |
| ACADIAN ASSET MANAGEMENT LLC | $778 | 170.883 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $664 | 145 | 0,00% | Azioni |
| Integrated Wealth Concepts LLC | $604 | 132 | 0,00% | Azioni |
| PRICE T ROWE ASSOCIATES INC /MD/ | $122 | 26.609 | 0,00% | Azioni |
| CWM, LLC | $86 | 25 | 0,00% | Azioni |
| SIMPLEX TRADING, LLC | $82 | 18 | 0,00% | Azioni |
| Virtu Financial LLC | $66 | 14.479 | 0,00% | Azioni |
| Parallel Advisors, LLC | $37 | 8 | 0,00% | Azioni |
Insider aziendali 24 insider · 9 dirigenti · 16 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David James Lennon | Chief Executive Officer | 02 Ottobre 2023 A | — | 0 | 0 | $0 |
| Scott M. Giacobello | CFO, Interim CEO & President | 03 Aprile 2023 A | 20.000 | 0 | 0 | $0 |
| Brendan Delaney | President and Chief Executive Officer | 01 Marzo 2023 A | 20.000 | 0 | 0 | $0 |
| Stephen J Hoffman | Chief Executive Officer | 14 Maggio 2019 A | 31.967 | 0 | 0 | $0 |
| Joseph H. Gardner | President | 16 Marzo 2020 A | 453.019 | 0 | 0 | $0 |
| Lorettta M Itri | Chief Medical Officer | 01 Marzo 2023 A | — | 0 | 0 | $0 |
| Kevin G. Peters | Chief Scientific Officer and Acting Chief Medical Officer Exhibit 24: Power of Attorney | 16 Marzo 2020 A | 320.536 | 0 | 0 | $0 |
| Michael W Rogers | Chief Financial and Chief Business Officer | 14 Maggio 2019 A | — | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 15 Febbraio 2019 A | — | 0 | 0 | $0 |
| Baiteng Zhao | Direttore | 12 Giugno 2026 A | — | 0 | 0 | $0 |
| Neil Desai | Direttore | 12 Giugno 2026 A | 1.453.543 | 0 | 0 | $0 |
| Emma Reeve | Direttore | 12 Giugno 2026 A | — | 0 | 0 | $0 |
| Mohammad Hirmand | Direttore | 12 Giugno 2026 A | — | 0 | 0 | $0 |
| Anupam Dalal | Direttore | 12 Giugno 2026 A | 4.685.912 | 0 | 0 | $0 |
| Richard E Maroun | Direttore | 12 Giugno 2026 A | — | 0 | 0 | $0 |
| Caley Castelein | Direttore | 12 Giugno 2026 A | 274.796 | 0 | 0 | $0 |
| Karin M. Hehenberger | Direttore | 15 Giugno 2023 A | — | 0 | 0 | $0 |
| Cheryl Cohen | Direttore | 17 Giugno 2021 A | 8.020 | 0 | 0 | $0 |
| Chau Quang Khuong | Direttore | 18 Giugno 2019 A | 5.193.946 | 0 | 0 | $0 |
| Satter Muneer A | Direttore | 18 Giugno 2019 A | 5.621.835 | 0 | 0 | $0 |
| Paul M Weiss | Direttore | 15 Marzo 2017 P | 1.576.167 | 0 | 0 | $0 |
| Dugel Pravin | — | 30 Giugno 2021 A | 12.568 | 0 | 0 | $0 |
| Steven Prelack | — | 30 Giugno 2021 A | 24.485 | 0 | 0 | $0 |
| Regina Marek | — | 16 Marzo 2020 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 13 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC, ANUPAM DALAL, Acuta Capital Fund, LP ×3 depositi | 18 Maggio 2026 | 9,00% | Modifica | Investimento passivo | SEC |
| Avoro Capital Advisors LLC, Avoro Ventures LLC, Behzad Aghazadeh ×6 depositi | 14 Maggio 2026 | 19,99% | Modifica | — | SEC |
| Neil Desai ×5 depositi | 06 Marzo 2025 | 4,90% | Modifica | — | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×5 depositi | 05 Marzo 2025 | 4,98% | Modifica | — | SEC |
| Muneer A. Satter (2) ×5 depositi | 12 Novembre 2021 | — | Deposito iniziale | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×4 depositi | 03 Settembre 2021 | — | Deposito iniziale | — | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 depositi | 15 Maggio 2020 | — | Deposito iniziale | — | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 depositi | 04 Ottobre 2018 | — | Deposito iniziale | — | SEC |
| Venture Investors Early Stage Fund IV Limited Partnership (2), VIESF IV GP LLC (2) | 27 Marzo 2017 | — | Deposito iniziale | — | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | 27 Marzo 2017 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 04 Aprile 2008 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 04 Aprile 2008 | — | Deposito iniziale | — | SEC |
| Argyris Vassiliou | 04 Aprile 2008 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 10 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 23.692 SH | 08 Agosto 2026 | Giornaliero |
| IWC · iShares Trust | 0,03% | 110.575 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 28.211 SH | 08 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | 0,01% | 278.917 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,00% | 719.241 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 20.759 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 470.854 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 887.972 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 187.597 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.409 SH | 08 Agosto 2026 | Giornaliero |